These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6145042)
1. First use of nafazatrom, a new antithrombotic drug, in pregnancy. Elder MG; Myatt L Lancet; 1984 Jun; 1(8390):1350. PubMed ID: 6145042 [No Abstract] [Full Text] [Related]
2. Protective actions of nafazatrom in traumatic shock. Lefer AM; Messenger M Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831 [TBL] [Abstract][Full Text] [Related]
5. Effects of nafazatrom on cardiovascular, sympathetic, and endocrine responses to hemorrhagic shock in conscious rats. Feuerstein G; Bayorh MA; Stull R; Goldstein DS; Zerbe RL; Ramwell PW; Faden AI Circ Shock; 1985; 17(3):223-32. PubMed ID: 3841032 [TBL] [Abstract][Full Text] [Related]
6. The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis. Shea MJ; Driscoll EM; Romson JL; Pitt B; Lucchesi BR Am Heart J; 1984 Apr; 107(4):629-37. PubMed ID: 6702555 [TBL] [Abstract][Full Text] [Related]
7. Investigations on the role of arachidonic acid metabolism pathways in the antithrombotic activity of nafazatrom and molsidomine. Massad L; Plotkine M; Boulu RG Thromb Res; 1988 Jun; 50(5):617-25. PubMed ID: 3137682 [TBL] [Abstract][Full Text] [Related]
8. Effects of nafazatrom and indomethacin on experimental myocardial ischemia in the anesthetized dog. Fiedler VB; Mardin M J Cardiovasc Pharmacol; 1985; 7(5):983-9. PubMed ID: 2413312 [TBL] [Abstract][Full Text] [Related]
9. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications. Zotz RB; Gerhardt A; Scharf RE J Thromb Haemost; 2004 Jul; 2(7):1182-92. PubMed ID: 15219203 [No Abstract] [Full Text] [Related]
10. The relationship between dose, pharmacokinetics, plasma-concentrations and antithrombotic effects of nafazatrom. Philipp E; Ritter W; Patzschke K Thromb Res Suppl; 1983; 4():129-33. PubMed ID: 6579706 [TBL] [Abstract][Full Text] [Related]
11. Reaction of the antithrombotic and antimetastatic agent, nafazatrom, with oxidizing radicals. Sevilla MD; Neta P; Marnett LJ Biochem Biophys Res Commun; 1983 Sep; 115(3):800-6. PubMed ID: 6312995 [TBL] [Abstract][Full Text] [Related]
12. Reduction of acute myocardial ischemia in rabbit hearts by nafazatrom. Fiedler VB J Cardiovasc Pharmacol; 1984; 6(2):318-24. PubMed ID: 6200722 [TBL] [Abstract][Full Text] [Related]
14. Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs. Weichert W; Pauliks V; Breddin HK Haemostasis; 1983; 13(1):61-71. PubMed ID: 6132858 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom. Marnett LJ; Siedlik PH; Ochs RC; Pagels WR; Das M; Honn KV; Warnock RH; Tainer BE; Eling TE Mol Pharmacol; 1984 Sep; 26(2):328-35. PubMed ID: 6434940 [TBL] [Abstract][Full Text] [Related]